Company Search:
Advanced Search
Sponsored Links
Affimed NV Company Snapshot
Affimed NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Affimed NV with three other companies in this sector in the United States: GW Pharmaceuticals PLC (2018 sales of $26.62 million of which 100% was Novel Therapeutics), Verastem Inc ($26.72 million of which 100% was Pharmaceuticals preparation), and Seres Therapeutics Inc ($28.27 million of which 100% was Pharmaceutical).

Sales Analysis. Sales increased substantially in 2018: Affimed NV reported sales of $27.97 million for the year ending December of 2018. This represents an increase of 1,121.4% versus 2017, when the company's sales were $2.29 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Affimed NV
  Stock Performance Chart for Affimed NV
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 2.90
(Figures in U.S. Dollars)
1 Week -4.0%   13 Weeks 6.2%  
4 Weeks 2.5%   52 Weeks -12.9%  
Affimed NV Key Data:
  Ticker: AFMD Country: Germany
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 27,966,001
(Year Ending Jan 2019).
Employees: 110
  Currency: U.S. Dollars Market Cap: 181,104,713
  Fiscal Yr Ends: December Shares Outstanding: 62,449,901
  Share Type: Common Closely Held Shares: 4,647,996
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.